About SCIderm
SCIderm is a company based in Hamburg (Germany) founded in 2005 was acquired by TFS in October 2016. SCIderm operates in a competitive market with competitors including Therapeutics, Innovaderm, SIT Skin Investigation and Technology, Cu-Tech and Bioskin, among others.
- Headquarter Hamburg, Germany
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website sciderm.de
- Social LinkedIn
- Acquired by TFS (Oct 2016)
Investors in SCIderm
SCIderm has secured backing from 1 investor. Prominent investors backing the company include TFSCRO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical research services are provided globally by TFS CRO. | 1996 | tfscro.com | Lund, Sweden |
Investor details for SCIderm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of SCIderm
2 dated milestones of SCIderm across 11 years, from founding to its latest funding, stage changes and deals.
- Founded SCIderm is founded.
- Exit Acquired by TFS.
Competitors of SCIderm
SCIderm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Therapeutics, Innovaderm, SIT Skin Investigation and Technology, Cu-Tech and Bioskin, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| therapeuticsinc.com | 1997 | San Diego, United States | $3M | – | Dermatology-focused CRO services for drugs, biologics, and devices are provided. | |
| innovaderm.com | 2000 | Montreal, Canada | – | – | Conducts clinical trials for dermatology research and patient care services. | |
| sit-skin.de | 1997 | Hamburg, Germany | – | 1,689 | Provides skin research, testing, and clinical studies for cosmetic and chemical sectors. | |
| cu-tech.com | 1993 | New York, United States | – | – | Full-service dermatology CRO for Phase I-IV clinical trials is operated. | |
| bioskincro.com | 1992 | Hamburg, Germany | – | – | Dermatology CRO offering clinical trial services for drugs, medical devices, food supplements and advanced cosmetics | |
| claimscro.com | 2007 | Mumbai, India | – | – | Operates as a contract research organization, delivering specialized research services. | |
| hill-top.com | 1947 | St. Petersburg, United States | – | – | Safety and efficacy studies for dermatological products are conducted. | |
| dermacellresearch.ca | 2016 | Laval, Canada | – | – | Provides clinical development services as a dermatology contract research organization. | |
| obqbio.com | 2020 | Seoul, South Korea | – | – | Researches and develops innovative bio products for medical and skincare applications globally. |
Detailed competitors of SCIderm
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to SCIderm
10 companies that operate in the same segment as SCIderm (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SCIderm
SCIderm was founded in 2005.
SCIderm is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.
SCIderm was a Germany based CRO exclusively focussed on dermatology related drug and device development, which was acquired by TFS, a mid tier CRO in October 2016. SCIderm had access to key opinion leaders and over 350 investigational sites in Europe and North America for the conduct of dermatology clinical trials at the time of acquisition. SCIderm had and continues to have close ties with the Dermatologikum Clinic in Hamburg, which apart from offering clinical development services for new therapy treatments in allergology, dermatology and aesthetics, also offers laboratory services in histology, mycology, bacteriology, molecular biology and quantitative RNA analysis identifying pathways of molecules and proves the mode-of-action in the early development stages.
SCIderm's top competitors include Therapeutics, Cu-Tech and Hill Top Research.
SCIderm has 1 investor. Key investors include TFSCRO.
Yes. SCIderm was acquired by TFS in October 2016.